human embryonic stem cell derived retinal tissue (Lineage cell therapeutics)

N/A

Report date: 2025/03/20 15:28:52

Base Information

Drug Namehuman embryonic stem cell derived retinal tissue (Lineage cell therapeutics)
Drug Alias Nameallogenic stem cell therapy (Lineage Cell Therapeutics)hESC-3D retinal tissue (Lineage Cell Therapeutics)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Retinal stem cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRetinitis PigmentosaVision Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLineage Cell Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesLineage Cell Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsRetinitis PigmentosaVision Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A